We will explore further the possibility that herpes simplex virus (HSV) modulates one or more cellular protein kinase families, either to promote efficient viral gene expression and DNA replication, or to prevent cellular responses that would inhibit efficient virus replication. As obligate intracellular parasites, viruses have profound effects on cellular proliferation, differentiation, and homeostasis. The machinery that regulates these states is often wholly or in part embodied in families of protein kinases and phosphatases that modulate the function of key effector proteins. These effector proteins are often transcription factors which induce gene expression required to sustain a particular phenotype, or to respond to extra-cellular signals, either trophic or stress-inducing. Establishment of primary herpesvirus infections on mucosal epithelium likely requires direct introduction of virus into the cycling cells of the basal cell layer, while reactivation of latent HSV occurs in post-mitotic neurons of dorsal root ganglia. Following anteriograde transport to the periphery, virus re-enters cells of the basal layer where additional rounds of replication results in ulcerative lesion development. In this portion of the Program Project Grant, we seek to extend our previous findings on the effects of HSV on the machinery that regulates cell cycle. Because the HSV replicative cycle occurs within cycling as well as postmitotic cells, we will manipulate the growth state of cell lines of both unlimited and limited life span. Specifically we will address questions about the role of virus infection on the activity of cyclin-dependent kinases (CDKs), the mechanisms of inhibition of CDKs, the viral gene products that contribute to regulation of CDKs, and the importance of regulating CDK activity for efficient virus replication. Armed with this information we can then experimentally address the importance of cell cycle regulation in the process of latency reactivation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA019014-25
Application #
6642889
Study Section
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
$434,203
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Nicholls, Thomas J; Nadalutti, Cristina A; Motori, Elisa et al. (2018) Topoisomerase 3? Is Required for Decatenation and Segregation of Human mtDNA. Mol Cell 69:9-23.e6
El-Mallawany, Nader Kim; Kamiyango, William; Villiera, Jimmy et al. (2018) Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol :1-7
Selitsky, Sara R; Marron, David; Mose, Lisle E et al. (2018) Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality. mSystems 3:
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Lyons, Danielle E; Yu, Kuan-Ping; Vander Heiden, Jason A et al. (2018) Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication. J Virol 92:
Bigi, Rachele; Landis, Justin T; An, Hyowon et al. (2018) Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 115:E11379-E11387
El-Mallawany, Nader Kim; Villiera, Jimmy; Kamiyango, William et al. (2018) Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease. Infect Agent Cancer 13:33
Kobayashi, E; Aga, M; Kondo, S et al. (2018) C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes. mSphere 3:
Hopcraft, Sharon E; Pattenden, Samantha G; James, Lindsey I et al. (2018) Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 14:e1007267

Showing the most recent 10 out of 324 publications